1. Home
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Hospital Universitari – HVH
  4. Articles científics - HVH
  5. View Item

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study

To access the full text documents, please follow this link: https://hdl.handle.net/11351/11202

Author

Guilbert, Theresa

Tolcachier, Alberto

Fiocchi, Alessandro

Katelaris, Constance

Phipatanakul, Wanda

Begin, Philippe

de Mir Messa, Ines

Other authors

Institut Català de la Salut

[Guilbert TW] Department of Pediatrics, Cincinnati Children’s Hospital and University of Cincinnati, Cincinnati, OH, USA. [Tolcachier A] Center for Allergy and Respiratory Diseases, Buenos Aires, Argentina. [Fiocchi AG] Bambino Gesù Children’s Hospital IRCCS, Rome, Italy. [Katelaris CH] Department of Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia. Immunology & Allergy Unit, Western Sydney University, Sydney, NSW, Australia. [Phipatanakul W] Department of Allergy and Immunology, Boston Children’s Hospital, Boston, MA, USA. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. [Begin P] Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, QC, Canada. [de Mir I] Unitat de Pneumologia Pediàtrica i Fibrosi Quística, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-03-18T13:38:57Z

2024-03-18T13:38:57Z

2024-03-05



Share

Abstract

Asthma control; Lung function; Pediatric asthma

Control del asma; Función pulmonar; Asma pediátrica

Control de l'asma; Funció pulmonar; Asma pediàtrica

Research sponsored by Sanofi and Regeneron Pharmaceuticals Inc. ClinicalTrials.gov Identifier: NCT02948959. Medical writing/editorial assistance was provided by Natalia Crespo, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals Inc., according to the Good Publication Practice guidelines: 2022 update.

Document Type

Article

Published version

Language

English

Subjects and keywords

Asma infantil; Anticossos monoclonals - Ús terapèutic; DISEASES::Respiratory Tract Diseases::Bronchial Diseases::Asthma; Other subheadings::Other subheadings::Other subheadings::/drug therapy; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal; Other subheadings::Other subheadings::/therapeutic use; NAMED GROUPS::Persons::Age Groups::Child; ENFERMEDADES::enfermedades respiratorias::enfermedades bronquiales::asma; Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales; Otros calificadores::Otros calificadores::/uso terapéutico; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño

Publisher

Dove Medical Press

Related items

Journal of Asthma and Allergy;17

https://doi.org/10.2147/JAA.S416292

Recommended citation

This citation was generated automatically.

Export

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Rights

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)

Articles científics - HVH [3440]